ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CELU Celularity Inc

3.00
-0.03 (-0.99%)
May 01 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 9,517
Bid Price 2.75
Ask Price 6.00
News -
Day High 3.075

Low
1.59

52 Week Range

High
8.90

Day Low 2.95
Share Name Share Symbol Market Stock Type
Celularity Inc CELU NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.03 -0.99% 3.00 19:00:00
Open Price Low Price High Price Close Price Previous Close
3.03 2.95 3.075 3.02 3.03
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
105 9,517 US$ 3.03 US$ 28,791 - 1.59 - 8.90
Last Trade Type Quantity Price Currency
15:59:52 formt 802 US$ 3.00 USD

Celularity Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
222.19M 21.78M - 17.98M 14.19M 0.65 15.66
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Celularity News

Date Time Source News Article
4/22/202407:00GlobeNewswire Inc.Celularity Inc. to Host Investor and Analyst Research &..
4/19/202416:30GlobeNewswire Inc.Celularity Inc. Announces Receipt of Nasdaq Notice Regarding..
4/18/202415:30GlobeNewswire Inc.Celularity Abstract “Emerging Technologies for the..
4/15/202407:00GlobeNewswire Inc.Celularity Announces Net Sales Trending Ahead of..
4/08/202408:00GlobeNewswire Inc.Celularity to Present Data Showing Senescent Cell..
3/26/202408:00GlobeNewswire Inc.Celularity Receives Healthcare Common Procedure Coding..
3/20/202408:15GlobeNewswire Inc.Celularity Submits Request to U.S. FDA for Orphan Drug..
3/14/202408:15GlobeNewswire Inc.Celularity CEO to Present on Cell Therapy’s Potential to..
3/12/202408:20GlobeNewswire Inc.Celularity CEO to Present Keynote Address at 2024 Society..
3/07/202408:35GlobeNewswire Inc.Celularity to Present Data Showing Cancer Tumor Reduction by..
2/26/202416:15Edgar (US Regulatory)Form 8-K - Current report
2/23/202415:10GlobeNewswire Inc.Celularity Announces 1-for-10 Reverse Stock Split
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CELU Message Board. Create One! See More Posts on CELU Message Board See More Message Board Posts

Historical CELU Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.233.742.89483.0974,343-0.23-7.12%
1 Month4.975.692.89483.7847,588-1.97-39.64%
3 Months4.6817.972.89484.41207,959-1.68-35.91%
6 Months2.3457.971.593.061,341,7740.65527.93%
1 Year6.108.901.593.531,008,306-3.10-50.82%
3 Years107.191134.001.5917.72629,059-104.19-97.20%
5 Years107.191134.001.5917.72629,059-104.19-97.20%

Celularity Description

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases.

Your Recent History

Delayed Upgrade Clock